Objectives To determine whether cardiac magnetic resonance (CMR) in vivo T1-mapping can measure myocardial area at risk (AAR) compared with microspheres or T2-mapping CMR. Background If T2-weighted CMR is abnormal in the AAR due to edema related to myocardial ischemia, then T1-weighted CMR should also be able to detect and accurately quantify AAR. Methods Dogs (n=9) underwent a 2 hour coronary occlusion followed by 4 hours of reperfusion. CMR of the left ventricle was performed for mapping of T1 and T2 prior to any contrast administration. AAR was defined as regions which had a T1 or T2 value (ms) greater than 2SD from remote, and regions with microsphere blood flow (ml/min/g) during occlusion less than 2SD from remote. Infarct size was determined by triphenyltetrazolium chloride staining. Results The relaxation parameters T1 and T2 were increased in the AAR compared to remote myocardium (T1: 1133±55 vs. 915±33ms, T2: 71±6 vs. 49±3 ms; mean±SD). On a slice-by-slice basis (n=78 slices), AAR by T1- and T2-mapping correlated (R2=0.95, p<0.001) with good agreement (0.4±16.6 % of slice, mean±2SD). On a whole-heart analysis, T1 measurements of left ventricular mass, AAR and myocardial salvage correlated to microsphere measures (R2=0.94) with good agreement (−1.4±11.2 g of myocardium; mean±2SD). Corresponding T2 measurements of left ventricular mass, AAR, and salvage correlated to microsphere analysis (R2=0.96, agreement 1.6±9.2 g of myocardium; mean±2SD). Median infarct size was 30% of the AAR (range 12–52). Conclusions For determining area at risk after acute myocardial infarction, non-contrast T1-mapping and T2-mapping sequences yield similar quantitative results, and both agree well with microspheres. The relaxation properties T1 and T2 both change in a way that is consistent with the presence of myocardial edema following myocardial ischemia/reperfusion.
Quantification of myocardial T1 relaxation has potential value in the diagnosis of both ischemic and non-ischemic cardiomyopathies. Image acquisition using the Modified Look-Locker Inversion Recovery technique is clinically feasible for T1 mapping. However, respiratory motion limits its applicability and degrades the accuracy of T1 estimation. The robust registration of acquired inversion recovery images is particularly challenging due to the large changes in image contrast, especially for those images acquired near the signal null point of the inversion recovery and other inversion times for which there is little tissue contrast. In this paper, we propose a novel motion correction algorithm. This approach is based on estimating synthetic images presenting contrast changes similar to the acquired images. The estimation of synthetic images is formulated as a variational energy minimization problem. Validation on a consecutive patient data cohort shows that this strategy can perform robust non-rigid registration to align inversion recovery images experiencing significant motion and lead to suppression of motion induced artifacts in the T1 map.
Purpose To compare the utility of magnetic resonance elastography (MRE) and diffusion-weighted imaging (DWI) in characterizing fibrosis and chronic hepatitis in patients with chronic liver diseases. MATERIALS AND METHODS Following IRB approval, 76 patients with chronic liver disease underwent abdominal MRI, MRE and DWI. Severities of liver fibrosis and chronic hepatitis were graded by histopathologic analysis according to standard disease-specific classification. The overall predictive ability of MRE and DWI in assessment of fibrosis was compared by constructing a receiver operating characteristic (ROC) curve and calculating the area under the curve (AUC) based on histopathologic analysis. RESULTS Using ROC analysis, MRE showed greater capability than DWI in discriminating stage 2 or greater (≥F2), stage 3 or greater (≥F3), cirrhosis (≥F4) shown as significant differences in AUC (P=0.003, P=0.001, P=0.001, respectively). Higher sensitivity/specificity were demonstrated by MRE in predicting fibrosis scores ≥F2 (91%/97%), scores ≥F3 (92%/95%), and scores F4 (95%/87%) compared to DWI (84%/82%, 88%/76%, and 85%/68%). Although MRE had higher ability in identification of liver with fibrosis scores ≥F1 than DWI, a significant difference was not seen (P=0.398). Stiffness values on MRE increased in relation to increasing severity of fibrosis as confirmed by histopathology scores; however, a consistent relationship between apparent diffusion coefficient (ADC) values and stage of fibrosis was not demonstrated. In addition, liver tissue with chronic hepatitis preceding fibrosis may account for mild elevation of liver stiffness. CONCLUSIONS MRE had greater predictive ability in distinguishing the stages of liver fibrosis compared with DWI.
Conventional approaches for fat and water discrimination based on chemical-shift fat suppression have reduced ability to characterize fatty infiltration due to poor contrast of microscopic fat. The multiecho Dixon approach to water and fat separation has advantages over chemical-shift fat suppression: 1) water and fat images can be acquired in a single breathhold, avoiding misregistration; 2) fat has positive contrast; 3) the method is compatible with precontrast and late-enhancement imaging, 4) less susceptible to partial-volume effects, and 5) robust in the presence of background field variation; and 6) for the bandwidth implemented, chemical-shift artifact is decreased. The proposed technique was applied successfully in all 28 patients studied. This included 10 studies with indication of coronary artery disease (CAD), of which four cases with chronic myocardial infarction (MI) exhibited fatty infiltration; 13 studies to rule out arrhythmogenic right ventricular cardiomyopathy (ARVC), of which there were three cases with fibrofatty infiltration and two confirmed with ARVC; and five cases of cardiac masses (two lipomas). The precontrast contrast-tonoise ratio (CNR) of intramyocardial fat was greatly improved, by 240% relative to conventional fat suppression. For the parameters implemented, the signal-to-noise ratio (SNR) was decreased by 30% relative to conventional late enhancement
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.
hi@scite.ai
10624 S. Eastern Ave., Ste. A-614
Henderson, NV 89052, USA
Copyright © 2024 scite LLC. All rights reserved.
Made with 💙 for researchers
Part of the Research Solutions Family.